Citation Formats
NIVOLUMAB FOR RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: EXPERIENCE IN TURKEY
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

B. Ferhanoglu Et Al. , "NIVOLUMAB FOR RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: EXPERIENCE IN TURKEY," 22nd Congress of the European-Hematology-Association , vol.102, Madrid, Spain, pp.84-85, 2017

Ferhanoglu, B. Et Al. 2017. NIVOLUMAB FOR RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: EXPERIENCE IN TURKEY. 22nd Congress of the European-Hematology-Association , (Madrid, Spain), 84-85.

Ferhanoglu, B., Bekoz, H., Karadurmus, N., Paydas, S., Gulbas, Z., Turker, A., ... Toptas, T.(2017). NIVOLUMAB FOR RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: EXPERIENCE IN TURKEY . 22nd Congress of the European-Hematology-Association (pp.84-85). Madrid, Spain

Ferhanoglu, B. Et Al. "NIVOLUMAB FOR RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: EXPERIENCE IN TURKEY," 22nd Congress of the European-Hematology-Association, Madrid, Spain, 2017

Ferhanoglu, B. Et Al. "NIVOLUMAB FOR RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: EXPERIENCE IN TURKEY." 22nd Congress of the European-Hematology-Association , Madrid, Spain, pp.84-85, 2017

Ferhanoglu, B. Et Al. (2017) . "NIVOLUMAB FOR RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: EXPERIENCE IN TURKEY." 22nd Congress of the European-Hematology-Association , Madrid, Spain, pp.84-85.

@conferencepaper{conferencepaper, author={B. Ferhanoglu Et Al. }, title={NIVOLUMAB FOR RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: EXPERIENCE IN TURKEY}, congress name={22nd Congress of the European-Hematology-Association}, city={Madrid}, country={Spain}, year={2017}, pages={84-85} }